Vanguard Group Inc Vera Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,001,108 shares of VERA stock, worth $63.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,001,108

Previous 2,918,423 2.83%

Holding current value

$63.4 Million

Previous $70.1 Million 0.86%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$18.86 - $32.0 $1.56 Million - $2.65 Million	82,685 Added 2.83%	3,001,108 $70.7 Million
Q1 2025 May 09, 2025	SELL	$24.02 - $43.22 $748,006 - $1.35 Million	-31,141 Reduced 1.06%	2,918,423 $70.1 Million
Q4 2024 Feb 11, 2025	BUY	$38.64 - $49.75 $14.3 Million - $18.4 Million	369,387 Added 14.32%	2,949,564 $125 Million
Q3 2024 Nov 13, 2024	BUY	$34.09 - $46.71 $1.91 Million - $2.62 Million	56,001 Added 2.22%	2,580,177 $114 Million
Q2 2024 Aug 13, 2024	BUY	$33.72 - $48.82 $12.7 Million - $18.3 Million	375,462 Added 17.47%	2,524,176 $91.3 Million
Q1 2024 May 10, 2024	BUY	$14.91 - $49.14 $7.68 Million - $25.3 Million	515,106 Added 31.53%	2,148,714 $92.7 Million
Q4 2023 Feb 14, 2024	BUY	$9.29 - $16.0 $550,135 - $947,488	59,218 Added 3.76%	1,633,608 $25.1 Million
Q3 2023 Nov 14, 2023	BUY	$13.71 - $19.64 $1.84 Million - $2.63 Million	134,125 Added 9.31%	1,574,390 $21.6 Million
Q2 2023 Aug 14, 2023	BUY	$6.11 - $17.83 $277,479 - $809,731	45,414 Added 3.26%	1,440,265 $23.1 Million
Q1 2023 May 15, 2023	BUY	$5.41 - $18.3 $3.39 Million - $11.5 Million	627,318 Added 81.73%	1,394,851 $10.8 Million
Q4 2022 Feb 10, 2023	BUY	$15.74 - $22.19 $136,953 - $193,075	8,701 Added 1.15%	767,533 $14.9 Million
Q3 2022 Nov 14, 2022	BUY	$13.27 - $22.31 $1.09 Million - $1.83 Million	81,895 Added 12.1%	758,832 $16.2 Million
Q2 2022 Aug 12, 2022	BUY	$12.82 - $23.4 $755,533 - $1.38 Million	58,934 Added 9.54%	676,937 $9.21 Million
Q1 2022 May 13, 2022	BUY	$17.8 - $28.06 $4.08 Million - $6.43 Million	229,025 Added 58.88%	618,003 $14.5 Million
Q4 2021 Feb 14, 2022	BUY	$15.01 - $35.8 $2.15 Million - $5.12 Million	143,143 Added 58.23%	388,978 $10.4 Million
Q3 2021 Nov 12, 2021	BUY	$13.71 - $30.6 $2.65 Million - $5.92 Million	193,567 Added 370.34%	245,835 $4.27 Million
Q2 2021 Aug 13, 2021	BUY	$11.5 - $19.97 $601,082 - $1.04 Million	52,268 New	52,268 $693,000

Others Institutions Holding VERA

# of Institutions

199

Shares Held

64.6M

Call Options Held

1.58M

Put Options Held

365K

View Full List

About Vera Therapeutics, Inc.

Ticker VERA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,042,300
Market Cap $572M
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...

More about VERA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Vera Therapeutics, Inc. Transaction History